We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Neuropharm | LSE:NPH | London | Ordinary Share | GB00B1NPJJ01 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
| | | +------------------------------------------------------+---------------+ | Amortisation expense for the period | - | +------------------------------------------------------+---------------+ | Balance as at 31 December 2009 | 50 | +------------------------------------------------------+---------------+ | | | +------------------------------------------------------+---------------+ | Carrying amount | | +------------------------------------------------------+---------------+ | | | +------------------------------------------------------+---------------+ | 31 December 2008 | - | +------------------------------------------------------+---------------+ | | | +------------------------------------------------------+---------------+ | 30 June 2009 | - | +------------------------------------------------------+---------------+ | | | +------------------------------------------------------+---------------+ | 31 December 2009 | - | +------------------------------------------------------+---------------+ During the six months ended 31 December 2008, the Company impaired in full the value of the intangible asset, since there remained uncertainty regarding funding, the future of NPL-2008 and the Company. 7. PROPERTY, PLANT AND EQUIPMENT +------------------------------------+---------+-----------+-----------+---------+----------+ | | Tooling | Office | Furniture | Total | | | | GBP'000 | equipment | and | GBP'000 | | | | | GBP'000 | fixtures | | | | | | | GBP'000 | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Cost | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 1 July 2008 | 175 | 19 | 6 | 200 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Additions | - | 5 | - | 5 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 31 December 2008 | 175 | 24 | 6 | 205 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Additions | - | 7 | - | 7 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 30 June 2009 | 175 | 31 | 6 | 212 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Additions | - | - | - | - | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 31 December 2009 | 175 | 31 | 6 | 212 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Accumulated depreciation and | | | | | | | impairment | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 1 July 2008 | 9 | 8 | 2 | 19 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Depreciation expense for the | 17 | 3 | 1 | 21 | | | period | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Impairment loss charged to income | 149 | - | - | 149 | | | statement | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 31 December 2008 | 175 | 11 | 3 | 189 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Depreciation expense for the | - | 6 | 1 | 7 | | | period | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 30 June 2009 | 175 | 17 | 4 | 196 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Depreciation expense for the | - | 4 | 1 | 5 | | | period | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | | +------------------------------------+---------+-----------+-----------+---------+----------+ | Balance as at 31 December 2009 | 175 | 21 | 5 | 201 | | +------------------------------------+---------+-----------+-----------+---------+----------+ | | | | | | +------------------------------------+---------+-----------+-----------+--------------------+ | Carrying amount | | | | | +------------------------------------+---------+-----------+-----------+--------------------+ | | | | | | +------------------------------------+---------+-----------+-----------+--------------------+ | 31 December 2008 | - | 13 | 3 | 16 | +------------------------------------+---------+-----------+-----------+--------------------+ | | | | | | +------------------------------------+---------+-----------+-----------+--------------------+ | 30 June 2009 | - | 14 | 2 | 16 | +------------------------------------+---------+-----------+-----------+--------------------+ | | | | | | +------------------------------------+---------+-----------+-----------+--------------------+ | 31 December 2009 | - | 10 | 1 | 11 | +------------------------------------+---------+-----------+-----------+---------+----------+ During the six months ended 31 December 2008, the Company impaired in full the value of the tooling, since there remained uncertainty regarding funding, the future of NPL-2008 and the Company. 8. NOTES TO THE CASH FLOW STATEMENT +---------------------------------------------+---------+---------+---------+ | | Six | Six | Year | | | months | months | ended | | | ended | ended | 30 | | | 31 Dec | 31 Dec | June | | | 2009 | 2008 | 2009 | | | GBP'000 | GBP'000 | GBP'000 | +---------------------------------------------+---------+---------+---------+ | | | | | +---------------------------------------------+---------+---------+---------+ | Operating loss | (1,245) | (4,513) | (7,635) | +---------------------------------------------+---------+---------+---------+
1 Year Neuropharm Chart |
1 Month Neuropharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions